Cipla

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE059A01026
  • NSEID: CIPLA
  • BSEID: 500087
INR
1,414.95
-1.05 (-0.07%)
BSENSE

Nov 20

BSE+NSE Vol: 15.67 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 597145,
    "name": "Cipla",
    "stock_name": "Cipla",
    "full_name": "Cipla Ltd.",
    "name_url": "stocks-analysis/cipla",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,414.95",
    "chg": -1.05,
    "chgp": "-0.07%",
    "dir": -1,
    "prev_price": "1,416.00",
    "mcapval": "114,744.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500087,
    "symbol": "CIPLA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE059A01026",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "15.67 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/cipla-597145-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cipla Ltd Gains 1.58%: 3 Key Drivers Behind This Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-gains-158-3-key-drivers-behind-this-weeks-momentum-4270737",
        "imagepath": "",
        "date": "2026-11-21 17:01:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Week opens at Rs.1,394.00 with marginal gain</p>\n                    <p><strong>18 Nov:</strong> Intraday high of Rs.1,425.00 with 3.17% surge</p>\n                    <p><strong>18 Nov:</strong> Surge in call option activity near Rs.1,430 strike</p>\n                    <p><strong>18 Nov:</strong> Sharp 31.74% jump in derivatives open interest</p>\n                    <p><strong>20 Nov:</strong> Week closes at Rs.1,414.95, up 1.58%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,394.00</d..."
      },
      {
        "title": "P/E at 36.8 vs Industry's 39.5: What the Data Shows for Cipla Ltd.",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-4268980",
        "imagepath": "",
        "date": "2026-11-20 09:20:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: A Slight Discount to Industry P/E</strong></p>\n                <p>The current P/E of 36.84 for <a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"stk\">Cipla Ltd.</a> represents a modest discount of approximately 6.8% relative to the sector average of 39.53. This suggests that the market is pricing the stock with a slightly more cautious outlook compared to its peers. Given the pharmaceutical sector’s typical premium valuations driven by innovation and patent portfolios, Cipla’s valuation indicates tempered expectations, possibly reflecting recent performance challenges or sector headwinds. <a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"stk\">Cipla Ltd.</a>’s large-cap status with a market capitalisation of..."
      },
      {
        "title": "P/E at 36.94 vs Industry's 39.30: What the Data Shows for Cipla Ltd.",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-navigating-nifty-50-membership-amid-mixed-performance-and-institutional-shifts-4267776",
        "imagepath": "",
        "date": "2026-11-19 09:20:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Discount to Industry P/E</strong></p>\n                <p><a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"stk\">Cipla Ltd.</a> currently trades at a P/E of 36.94, which is approximately 6.1% below the Pharmaceuticals & Biotechnology industry average of 39.30. This discount suggests that the market is pricing in either a relatively subdued growth outlook or concerns over near-term earnings momentum compared to its sector peers. Given the sector’s average valuation, Cipla’s lower P/E could be interpreted as a valuation cushion, but it also raises questions about the sustainability of its earnings trajectory. <a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"stk\">Cipla Ltd.</a>’s market capitalisation stands a..."
      },
      {
        "title": "Cipla Ltd Sees Sharp Surge in Derivatives Open Interest Amid Bullish Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-sees-sharp-surge-in-derivatives-open-interest-amid-bullish-momentum-4267244",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CiplaLtd_oi_spurts_by_underlying_4267244.png",
        "date": "2026-11-18 15:00:28",
        "description": "Cipla Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment on 18 Nov 2026, signalling heightened market interest and potential directional bets. The stock outperformed its sector peers and broader indices, reflecting renewed investor confidence amid evolving market positioning."
      },
      {
        "title": "Cipla Ltd Sees Sharp Open Interest Surge Signalling Renewed Market Interest",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-sees-sharp-open-interest-surge-signalling-renewed-market-interest-4267159",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CiplaLtd_oi_spurts_by_underlying_4267159.png",
        "date": "2026-11-18 14:00:21",
        "description": "Cipla Ltd., a leading pharmaceutical and biotechnology company, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market interest and potential directional bets. The stock outperformed its sector and broader indices, supported by robust volume and positive price action, prompting a reassessment of its market positioning and outlook."
      },
      {
        "title": "Cipla Ltd Sees Sharp Open Interest Surge Amid Bullish Derivatives Activity",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-sees-sharp-open-interest-surge-amid-bullish-derivatives-activity-4267096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CiplaLtd_oi_spurts_by_underlying_4267096.png",
        "date": "2026-11-18 13:00:15",
        "description": "Cipla Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market interest and potential directional bets. The stock outperformed its sector and broader indices, supported by strong volume and positive price action, reflecting a shift in investor positioning and sentiment."
      },
      {
        "title": "12,969 Call Contracts Traded on Cipla Ltd. as Stock Edges Closer to Rs 1,430 Strike",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-sees-surge-in-call-option-activity-ahead-of-november-expiry-4267128",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CiplaLtd_most_active_stocks_calls_4267128.png",
        "date": "2026-11-18 13:00:06",
        "description": "On 18 Nov 2026, Cipla Ltd. witnessed significant call option activity with 12,969 contracts traded at the Rs 1,430 strike price, closely aligned with the stock’s closing price of Rs 1,424.60. This synchronisation between the derivatives and cash markets highlights a focused directional stance ahead of the 23 Nov expiry."
      },
      {
        "title": "Cipla Ltd Sees Sharp Open Interest Surge Amid Bullish Derivatives Activity",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-sees-sharp-open-interest-surge-amid-bullish-derivatives-activity-4267042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CiplaLtd_oi_spurts_by_underlying_4267042.png",
        "date": "2026-11-18 12:00:13",
        "description": "Cipla Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, witnessed a notable surge in open interest (OI) in its derivatives segment on 18 Nov 2026, signalling increased market participation and potential directional bets. The stock outperformed its sector peers and broader indices, reflecting renewed investor confidence amid evolving market dynamics."
      },
      {
        "title": "Cipla Ltd. Surges 3.17% to Day's High of Rs 1425 — Outperforms Sector by 2.67 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/cipla-ltd-hits-intraday-high-with-317-surge-on-18-nov-2026-4267022",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/CiplaLtd_priceRelatedfactors_4267022.png",
        "date": "2026-11-18 11:31:31",
        "description": "The Sensex declined 0.41% on 18 Nov 2026, yet Cipla Ltd. surged 3.17%, outperforming its Pharmaceuticals &amp; Biotechnology sector by 2.67 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly weaker market environment."
      }
    ],
    "total": 333,
    "sid": "597145",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/cipla-597145"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Nov-2026",
      "details": "Newspaper advertisement for Notice of Postal Ballot and e-voting information.",
      "source": "BSE"
    },
    {
      "caption": "Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge Long Island New York USA",
      "datetime": "17-Nov-2026",
      "details": "Please find enclosed intimation",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "16-Nov-2026",
      "details": "Postal Ballot Notice dated 27th October 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has declared <strong>650%</strong> dividend, ex-date: 05 Jun 26",
          "dt": "2026-06-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has announced <strong>3:2</strong> bonus issue, ex-date: 24 Apr 06",
          "dt": "2006-04-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Nov-2026 | Source : BSE

Newspaper advertisement for Notice of Postal Ballot and e-voting information.

Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge Long Island New York USA

17-Nov-2026 | Source : BSE

Please find enclosed intimation

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

16-Nov-2026 | Source : BSE

Postal Ballot Notice dated 27th October 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Cipla Ltd. has declared 650% dividend, ex-date: 05 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Cipla Ltd. has announced 3:2 bonus issue, ex-date: 24 Apr 06

stock-summary
RIGHTS

No Rights history available